miR-137 targets the inhibition of TCF4 to reverse the progression of osteoarthritis through the AMPK/NF-κB signaling pathway | Zendy

Jinyu Wang | Zendy; Liming Fang | Zendy; Lili Ye | Zendy; Shiliang Ma | Zendy; Haoran Huang | Zendy; Xiaoquan Lan | Zendy; Jianlin Ma | Zendy

Open Access

miR-137 targets the inhibition of TCF4 to reverse the progression of osteoarthritis through the AMPK/NF-κB signaling pathway

Author(s) -

Jinyu Wang,

Liming Fang,

Lili Ye,

Shiliang Ma,

Haoran Huang,

Xiaoquan Lan,

Jianlin Ma

Publication year - 2020

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20200466

Subject(s) - chondrocyte , ampk , apoptosis , tcf4 , chemistry , inflammation , cartilage , signal transduction , transcription factor , microbiology and biotechnology , osteoarthritis , nf κb , medicine , cancer research , endocrinology , biology , gene , protein kinase a , enhancer , anatomy , phosphorylation , pathology , biochemistry , alternative medicine

To explore the regulatory mechanism of miR-137 and transcription factor 4 (TCF4) in the progression of osteoarthritis (OA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research